Search by Drug Name or NDC

    NDC 65162-0033-10 Acetaminophen and Codeine 300; 30 mg/1; mg/1 Details

    Acetaminophen and Codeine 300; 30 mg/1; mg/1

    Acetaminophen and Codeine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is ACETAMINOPHEN; CODEINE PHOSPHATE.

    Product Information

    NDC 65162-0033
    Product ID 65162-033_a37e5b33-eb88-4ad2-bedc-c29ac46a16f1
    Associated GPIs 65991002050315
    GCN Sequence Number 004165
    GCN Sequence Number Description acetaminophen with codeine TABLET 300MG-30MG ORAL
    HIC3 H3U
    HIC3 Description OPIOID ANALGESIC AND NON-SALICYLATE ANALGESICS
    GCN 70134
    HICL Sequence Number 001717
    HICL Sequence Number Description ACETAMINOPHEN WITH CODEINE PHOSPHATE
    Brand/Generic Generic
    Proprietary Name Acetaminophen and Codeine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acetaminophen and Codeine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 300; 30
    Active Ingredient Units mg/1; mg/1
    Substance Name ACETAMINOPHEN; CODEINE PHOSPHATE
    Labeler Name Amneal Pharmaceuticals LLC
    Pharmaceutical Class Full Opioid Agonists [MoA], Opioid Agonist [EPC]
    DEA Schedule CIII
    Marketing Category ANDA
    Application Number ANDA040779
    Listing Certified Through 2024-12-31

    Package

    NDC 65162-0033-10 (65162003310)

    NDC Package Code 65162-033-10
    Billing NDC 65162003310
    Package 100 TABLET in 1 BOTTLE (65162-033-10)
    Marketing Start Date 2008-05-29
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.26427
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ACETAMINOPHEN-COD #3 TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis